Filtered By:
Cancer: Cancer

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 872 results found since Jan 2013.

Gut immune homeostasis: the immunomodulatory role of < em > Bacillus clausii < /em > , from basic to clinical evidence
Expert Rev Clin Immunol. 2022 Jun 8. doi: 10.1080/1744666X.2022.2085559. Online ahead of print.ABSTRACTINTRODUCTION: The gut microbiota affects the development of the gut immune system in early life. Perturbations to microbiota structure and composition during this period can have long-term consequences on the health of the individual, through its effects on the immune system. Research in the last few decades has shown that probiotic administration can reverse these effects in strain- and environment-specific ways. Bacillus clausii (B. clausii) has been in use for many decades as a safe and efficacious probiotic, but its m...
Source: Expert Review of Clinical Immunology - June 8, 2022 Category: Allergy & Immunology Authors: Rosa Mar ía Wong-Chew Jo-Anne A de Castro Lorenzo Morelli Marcos Perez Metehan Ozen Source Type: research

Evaluation of pollutants in perfumes, colognes and health effects on the consumer: a systematic review
This article aims to review the relevant literature published up to August 2020 to determine whether perfumes and colognes can affect people's health. Relevant articles were identified through electronic search. A total of 562 articles were selected and finally 37 related articles were included in the study after the screening process. The results of this systematic study showed that phthalates, aldehydes, parabens and aluminum-based salts are the most important contaminants in aromatic products that cause side effects such as allergies, breast cancer, reproductive disorders, especially in males, skin allergies, nervous sy...
Source: Cancer Control - June 7, 2022 Category: Cancer & Oncology Authors: Zahra Kazemi Ehsan Aboutaleb Abbas Shahsavani Majid Kermani Zohre Kazemi Source Type: research

Concerns About Compounded Bioidentical Menopausal Hormone Therapy
Cancer J. 2022 May-Jun 01;28(3):241-245. doi: 10.1097/PPO.0000000000000597.ABSTRACTFollowing the release of the Women's Health Initiative data, women began to use compounded bioidentical hormone therapy (cBHT) in the misguided belief of greater safety and efficacy than traditional hormone therapy. New guidelines recommend government-approved hormone therapy for symptomatic healthy menopausal women younger than 60 years or within 10 years of menopause at the time of initiation. For women requesting bioidentical hormones, those similar to the hormones present before menopause, there are many government-approved hormone thera...
Source: Cancer Journal - May 20, 2022 Category: Cancer & Oncology Authors: JoAnn V Pinkerton Source Type: research